Clinical Dementia
Introduction
Today's focus is on dementia, covering its clinical aspects and molecular basis, as presented by both a clinician and a basic scientist. Dementia is a significant area of interest, as indicated by the high level of engagement from the audience.
What is Dementia?
We will explore the definition of dementia, the methods for diagnosing it using clinical criteria and biomarkers, and the available interventions, including pharmacological and non-pharmacological approaches. A notable figure in raising political awareness is Dame Barbara Windsor, who played Peggy Mitchell in EastEnders. Her meeting with Boris Johnson led to the establishment of a task force aimed at addressing dementia with similar urgency to the COVID-19 response. This initiative underscores the importance of government support and research funding in tackling dementia.
Economic Impact of Dementia
The estimated cost to the UK economy is substantial, reaching in 2024. A significant portion of this cost is attributed to unpaid care. This includes:
Loss of employment for individuals with dementia, affecting household income and economic productivity.
Essential care for frail and elderly individuals who require frequent hospitalization, straining healthcare resources.
Unpaid care provided by family members, reflecting both volunteering efforts and the necessity to support loved ones. This informal caregiving can lead to caregiver burnout and reduced quality of life.
Dementia is often perceived as a disease of old age, which is generally true. However, younger onset dementia exists, exemplified by the speaker running an April course by Abi. Early diagnosis and intervention are critical in younger onset cases to manage symptoms and improve quality of life.
Prevalence and Aging
The likelihood of developing dementia increases with age. Analyzing a graph:
The x-axis represents time, spanning from 2012 to projected values in 2051, illustrating the growing prevalence of dementia over time.
The colors indicate age groups, showing the distribution of dementia across different age demographics.
While the number of people with younger onset dementia remains relatively stable, the prevalence of dementia rises significantly in individuals aged 85 and above. This increase is correlated with increased longevity, as more people are living longer and reaching ages where dementia risk is higher. The prevalence of dementia roughly doubles every five years due to people living longer.
Diagnosing Dementia: Clinical Criteria
Dementia diagnosis involves both clinical assessments and the use of biomarkers. The clinical diagnosis, according to the DSM-5, includes three main components:
Decline in Cognition: A notable decrease in cognitive function compared to a previous baseline. Establishing this baseline is crucial, especially in individuals with pre-existing learning difficulties. This decline must be significant enough to represent a change from prior abilities.
Involvement of Multiple Cognitive Domains: The decline should affect more than one cognitive area. These domains include:
Memory: Specifically, the hippocampus, which is critical for forming new memories.
Executive Function: Prefrontal cortex, responsible for planning, decision-making, and problem-solving.
Language: Including both expressive and receptive language abilities.
Visual-Spatial Skills: Temporal-parietal lobe, essential for navigation and spatial orientation.
Attention: The ability to focus and maintain concentration.
Brain shrinkage (atrophy) often occurs unevenly, affecting specific areas associated with these cognitive domains. This pattern of atrophy can provide clues about the specific type of dementia.
Functional Impairment: Cognitive deficits must significantly interfere with daily activities and overall function. Common questions to assess this include:
Ability to continue working, indicating the impact on professional life.
Driving ability, assessing the safety and competence in operating a vehicle.
Ability to live independently, including managing personal care, finances, and household tasks.
Types of Dementia
The most common type of dementia is Alzheimer's disease, accounting for a significant proportion of cases. Other types include:
Vascular Dementia: Linked to hypertension, stroke, and other vascular risk factors.
Mixed Dementia: Combination of different pathologies, such as Alzheimer's disease and vascular dementia.
Lewy Body Dementia: Characterized by hallucinations, Parkinsonism, and fluctuating cognitive symptoms.
Frontotemporal Dementia: Affecting behavior, personality, and language functions.
Dementia associated with Parkinson's Disease: Occuring in advanced stages.
Diagnostic Process: History and Cognitive Tests
The diagnostic process involves gathering information through various methods:
History Taking:
Inquiring about cognitive impairments, focusing on memory, personality changes, and planning abilities. Detailed questioning helps to understand the nature and progression of cognitive decline.
Family input due to potential lack of insight from the patient. Collateral information from family members or caregivers is crucial for an accurate assessment.
Functional impact assessment (e.g., changes in independence, ability to manage finances). Evaluating the impact on daily life provides insights into the severity of dementia.
Tempo: Determining whether the changes occurred over years (typical of dementia) versus days or weeks (suggesting acute conditions). The speed of onset can help differentiate dementia from other conditions.
Identifying triggers and considering the bio-psychosocial model to differentiate from conditions like psychosis or depression. Addressing psychological and social factors is essential for a comprehensive evaluation.
Reviewing past medical and psychiatric history to assess vulnerability factors. A thorough review helps identify underlying conditions that may contribute to cognitive impairment.
Assessing vascular risk factors, such as hypertension, diabetes, and smoking.
Gathering social history, including baseline education and substance use. Chronic alcohol abuse can lead to cognitive impairment.
Family history to ascertain genetic predispositions, particularly in early-onset cases. Genetic factors play a role in some types of dementia.
Cognitive Assessment:
Basic cognitive tests (e.g., Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)). These tests provide a standardized way to assess cognitive function.
Cognitive Assessment Tools
Mini-Mental State Examination (MMSE): Quick assessment tool covering orientation, short-term memory, and other cognitive functions. It provides a global measure of cognitive status.
Montreal Cognitive Assessment (MoCA): More detailed, assessing visual-spatial skills and executive functions. It is more sensitive than MMSE in detecting mild cognitive impairment.
Adam Brooks Cognitive Examination (ACE): An even longer, more detailed exam that further examines nuances in language and other deficits. The ACE provides a comprehensive cognitive profile.
Neuropsychological Testing: Comprehensive battery of tests conducted by specialized psychologists, providing refined granularity on cognitive deficits. These tests offer detailed insights into specific cognitive strengths and weaknesses.
Brain Structure and Function
As people age, brains shrink, with that shrinkage being uneven in dementia. The brain areas that correlate depend on the type of dementia, for example:
Alzheimer's Disease: Affecting episodic memory. Correlated with the hippocampus and limbic system shrinking. This atrophy is a hallmark of Alzheimer's disease.
Behavioral Variant FTD (Frontotemporal Dementia): The frontal part of the brain shrinks faster causing behavioral changes. This leads to alterations in personality and social conduct.
Tools to check for structural shrinkage:
CT Scan: Quick and easily identifies atrophy. It is useful for detecting gross structural changes.
MRI: More in-depth analysis than CT Scan. MRI provides detailed images of brain structure.
PET Scan: Can analyze glucose and other activity in the brain. PET scans can identify metabolic changes associated with dementia.
Practical Assessment and History Taking
Collateral Histories: Asking family or friends about noticed changes (e.g., forgetfulness, disorientation, personality change). Their observations provide valuable information.
Cognitive Examination: Assessing different cognitive domains. This includes memory, executive function, language, and visual-spatial skills.
Montreal Cognitive Assessment (MoCA) Details
The MoCA tests numerous skills that are required for spatial awareness, memory, and sequential rule following. It is a comprehensive tool for assessing cognitive function.
A good point about the MoCA tool is it requires knowledgeable users to administer and interpret it to avoid common pitfalls. For instance, being drunk, or memorizing the answers. The test is also mainly for diagnostics, and not long term progression tracking. It is designed to identify cognitive impairment at a single point in time.
Addressing Cultural and Educational Biases in Testing
Key strategies includes language accommodations. The point that should be noted is the way you have to account for people in different ranges of educational levels or cultural backgrounds. While it is important measure impairment of cognition and function, it is important not to overly rely on them as it can potentially be unhelpful.
Investigations and Biomarkers
Routine Blood Tests: Including tests for syphilis, which can cause dementia. Blood tests can rule out other medical conditions.
Imaging: CT and MRI scans to assess brain structure. These scans help identify structural abnormalities.
Psychological Assessments: Detailed evaluations by psychologists. These assessments provide a comprehensive cognitive profile.
Cerebrospinal Fluid (CSF) Analysis: Measuring protein levels in spinal fluid to detect markers of neuronal death. CSF biomarkers can aid in the diagnosis of Alzheimer's disease.
PET Scans: Measuring brain activity and glucose metabolism. PET scans can detect metabolic changes associated with dementia.
Genetics Identifies some causes of dementia that are genetic.
Treatment and Management
In the past, limited treatments were available. However, recent advancements, particularly anti-amyloid therapies, show promise. This may shift the approach from palliation to chronic disease management. Some current things available:
Episode, and anticholinergic medications to manage cognitive symptoms.
Anti-inflammatories for cognitive treatment.
Stem cell treatment to regenerate the brain.
Amyloid therapy to reduce amyloid plaques.
Alzheimer's Disease Specifics
Typical Presentation: Impairment in episodic memory, with later development of visual-spatial and language problems. These symptoms progress over time.
Pathology: Brain shrinkage, amyloid plaques, and tau tangles. These pathological changes are hallmarks of Alzheimer's disease.
MRI Findings: Hippocampal atrophy. This atrophy is a characteristic feature on MRI scans.
Alzheimer's Disease Progression
Focuses on early detection through biomarkers, and pet traces when the amyloid is deposited even without symptoms. CSF can also be tested which rises the level of amino acid . It is also key to differentiate mild cognitive impairment from actual dementia.
Other Types of Dementia
Vascular Dementia: Related to blood pressure and small vessel disease. Managing vascular risk factors is crucial.
Semantic Dementia: Loss of word meaning. This impairs communication abilities.
Frontotemporal Dementia: Shrinkage in frontal and temporal regions. This leads to changes in behavior and personality.
Lewy Body Dementia:* Discussed by other speakers.
Post-Diagnosis Management
Emphasizing support and safety, including driving restrictions, and addressing long-term legal and care arrangements. This includes providing resources for patients and families.
Key Takeaways
Dementia is common and increasing due to longevity. It is a significant public health concern.
Alzheimer's disease is the most prevalent type. Understanding its pathology is essential.
Accurate patient history is essential for diagnosis. Collateral information is crucial.
Advancements in anti-amyloid therapies offer new treatment possibilities. These therapies may change the course of the disease.
Questions and Concerns
A interesting thought is surgery to fix volume loss of the brain to fix the problems. An interesting related hypothesis to this is that there is possibly a transmissible alzheimers where amyloid protein fold misfolding.
A thought on using machine learning techniques